DNA Methylation-Guided Prediction and Validation of TAAD Molecular Targets

Key Points

• Molecular targets for TAAD are predicted through DNA methylation analysis, highlighting new treatment possibilities.
• The study achieves a 95% accuracy rate in validating these targets based on diverse datasets.
• Prediction and validation involve correlating DNA methylation changes with gene expression levels in TAAD samples.
• The findings may enable novel therapeutic strategies for TAAD, warranting further exploration in clinical settings.